Rockport Venture Partners
VC Fund
Spring Lake, United States
Rockport Venture Partners is a unique private placement firm that specializes in raising private equity from a global network.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Rockport Venture Partners invests in
Stages Rockport Venture Partners invests in
Countries Rockport Venture Partners invests in
Investment Focus
Industry
- Health Care 4 (80%)
- Medical Device 3 (60%)
- Medical 2 (40%)
- Therapeutics 2 (40%)
- Biotechnology 2 (40%)
Stage
- Pre-Seed 1 (20%)
- Series B 1 (20%)
- Series C 1 (20%)
- Series F 1 (20%)
- Funding Round 1 (20%)
Country
- United States 4 (80%)
- India 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Okulo Aerospace
|
Okulo Aerospace is a drone technology company.It provides aircraft monitoring solutions that helps businesses to collect data and obtain useful information. | $995.1K / Pre-Seed / Jul 11, 2023 | |
CardioMEMS
|
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can beimplanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients. | $37.9M / May 10, 2010 | |
Cognoptix
|
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.The company was founded in 2001 and headquarteredin Marlborough, Massachusetts. | $18.5M / Series B / Oct 22, 2008 | |
FlowCardia
|
FlowCardia, Inc. is a medical device company founded in 2002 to design and develop a portfolio of innovative, catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. Chronic Total Occlusions (CTOs) are considered one of the last major clinical challenges in interventional therapy. Thehistoric absence of safe and effective CTO recanalization devices is a major reason a large number of patients are still referred to coronary and peripheral bypass surgery and lower limb amputation. | $30M / Series C / Aug 30, 2007 | |
Broncus Technologies
|
Broncus Technologies is a medical technology company focused on developing minimally-invasive medical devices for emphysema and other lung diseases. Broncus is investigating the Exhale emphysema product line to perform our patented treatment method called Airway Bypass. Airway Bypass could be the first minimally-invasive procedure for the treatmentof homogeneous, or diffuse, emphysema, which constitutes the majority of the emphysema patient population.Broncus is currently enrolling patients worldwide in our pivotal EASE Trial investigating a treatment of severe homogeneous emphysema.Broncus is located in Mountain View, CA (San Francisco Bay area).Broncus International is located in Nyon, Switzerland. | $29.5M / Series F / Sep 01, 2006 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Rockport Venture Partners invest in?
Rockport Venture Partners invests primarily in Health Care, Medical Device and Medical startups, most often at Pre-Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Rockport Venture Partners last invest?
The most recent investment recorded for Rockport Venture Partners closed in Jul 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
